MedPath

The effects of hyperbaric oxygen therapy on treatment of chronic prostatitis: randomized controlled preliminary study

Not Applicable
Conditions
Diseases of the genitourinary system
Registration Number
KCT0007108
Lead Sponsor
Yonsei University, Wonju Severance Christian Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Male
Target Recruitment
24
Inclusion Criteria

1) Men 19 to 60 years old with a history of pain or discomfort perceived in the prostate
region with no other lower urinary tract pathology for a minimum of 3 of the last 6 months
2) National Institutes of Health Chronic Prostatitis Symptom Index total score greater than 15
3) Ability to understand and the willingness to sign a written informed consent

Exclusion Criteria

1) History of other lower urinary tract pathology such as urinary tract cancer, urinary tract infection including acute prostatitis, neurogenic bladder, and surgery
2) Contraindication of hyperbaric oxygen therapy such as pneumothorax, cardiovascular surgery, chronic pulmonary obstructive disease, upper respiratory infection, fever, and cancer
3) Participants who were diagnosed as infectious or inflammatory disease, and musculoskeletal disease within recent 3 months
4) Men with female spouses who are pregnant, breastfeeding or refuse contraception

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ational Institutes of Health Chronic Prostatitis Symptom Index;Adverse event due to hyperbaric oxygen therapy
Secondary Outcome Measures
NameTimeMethod
International Prostate Symptom Score;International Erectile Function Index-5;Maximum flow rate;Postvoid residual urine
© Copyright 2025. All Rights Reserved by MedPath